ES248340A1 - Método para obtener una composicion en forma de dosificacion oral - Google Patents

Método para obtener una composicion en forma de dosificacion oral

Info

Publication number
ES248340A1
ES248340A1 ES0248340A ES248340A ES248340A1 ES 248340 A1 ES248340 A1 ES 248340A1 ES 0248340 A ES0248340 A ES 0248340A ES 248340 A ES248340 A ES 248340A ES 248340 A1 ES248340 A1 ES 248340A1
Authority
ES
Spain
Prior art keywords
plastic body
drug
ingestion
drug composition
plastic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0248340A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rohm and Haas Co
Original Assignee
Rohm and Haas Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohm and Haas Co filed Critical Rohm and Haas Co
Publication of ES248340A1 publication Critical patent/ES248340A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/07—Microporous membranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
ES0248340A 1958-10-10 1959-03-31 Método para obtener una composicion en forma de dosificacion oral Expired ES248340A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US766496A US2987445A (en) 1958-10-10 1958-10-10 Drug composition

Publications (1)

Publication Number Publication Date
ES248340A1 true ES248340A1 (es) 1959-08-16

Family

ID=25076606

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0248340A Expired ES248340A1 (es) 1958-10-10 1959-03-31 Método para obtener una composicion en forma de dosificacion oral

Country Status (3)

Country Link
US (1) US2987445A (es)
BE (1) BE575313A (es)
ES (1) ES248340A1 (es)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3039933A (en) * 1957-10-07 1962-06-19 Premo Pharmaceutical Lab Inc Ethyl cellulose-polyethylene glycol tablet matrix
US3048526A (en) * 1958-08-04 1962-08-07 Wander Company Medicinal tablet
US3070509A (en) * 1958-12-18 1962-12-25 Roehm & Haas Gmbh Process for coating medicaments
US3096248A (en) * 1959-04-06 1963-07-02 Rexall Drug & Chemical Company Method of making an encapsulated tablet
US3062720A (en) * 1959-05-20 1962-11-06 Philips Roxane Sustained release pharmaceutical tablet
GB900348A (en) * 1959-12-29 1962-07-04 Atomic Energy Authority Uk Improvements in or relating to fuel elements for nuclear reactors
GB972128A (en) * 1960-01-21 1964-10-07 Wellcome Found Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets
NL254052A (es) * 1960-03-31 1900-01-01
US3071476A (en) * 1960-05-12 1963-01-01 August R Werft Chewing device
NL264748A (es) * 1960-05-17
NL265428A (es) * 1960-06-06
US3073748A (en) * 1960-11-28 1963-01-15 Tanabe Seiyaku Co Coated medicaments
NL297088A (es) * 1961-01-31
US3136695A (en) * 1961-03-10 1964-06-09 Strong Cobb Arner Inc Anhydrous thixotropic gel sustained release therapeutic compositions and method of preparation
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3279996A (en) * 1962-08-28 1966-10-18 Jr David M Long Polysiloxane carrier for controlled release of drugs and other agents
NL297357A (es) * 1962-08-31
US3276949A (en) * 1963-05-07 1966-10-04 Olin Mathieson Tablets comprising calcium hypochlorite and sodium sulfate and method of preparation
US4115590A (en) * 1964-02-26 1978-09-19 Ethyl Corporation Binuclear phenols for reducing plasma lipid levels
US3916898A (en) * 1964-05-20 1975-11-04 Searle & Co Administration of medicaments and the like
US3391477A (en) * 1965-10-22 1968-07-09 Abbott Lab Educational model of pharmaceutical device
US3358687A (en) * 1965-12-06 1967-12-19 Sterling Drug Inc Suppositories
US3453360A (en) * 1966-04-27 1969-07-01 Abbott Lab Universally useful stock material for manufacturing plastic dosage units by compression tableting processes
US3499445A (en) * 1966-08-16 1970-03-10 Phytogen Prod Inc Animal husbandry
USRE28536E (en) * 1966-08-16 1975-09-02 Animal husbandry
US3487138A (en) * 1966-11-23 1969-12-30 Merck & Co Inc Process for preparing a delayed release medicinal tablet
SE353229B (es) * 1970-06-04 1973-01-29 Haessle Ab
US3920806A (en) * 1973-05-04 1975-11-18 Merck & Co Inc Growth promoting subcutaneous compositions
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
JPS5138412A (en) * 1974-09-24 1976-03-31 Nippon Kayaku Kk Kokoseizai no seiho
US4421742A (en) * 1977-02-08 1983-12-20 Dr. Werner Freyberg Chemische Fabrik Delitia Nachf. Phosphine producing pesticide and method of manufacture therefor
US4217898A (en) * 1978-10-23 1980-08-19 Alza Corporation System with microporous reservoir having surface for diffusional delivery of agent
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
JPS57500432A (es) * 1980-03-20 1982-03-11
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
JPS57134498A (en) * 1981-02-12 1982-08-19 Hayashibara Biochem Lab Inc Anhydrous crystalline maltitol and its preparation and use
IT1168014B (it) * 1981-08-05 1987-05-20 Erba Farmitalia Forme farmaceutiche a cessione protratta
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4851231A (en) * 1982-12-13 1989-07-25 Alza Corporation System for delivering drug in selected environment of use
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
GB2141023B (en) * 1983-06-06 1986-09-03 Robins Co Inc A H Delayed release formulations
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
USRE33994E (en) * 1983-08-16 1992-07-14 Burroughs Wellcome Co. Pharmaceutical delivery system
EP0168522A3 (de) * 1983-11-18 1986-11-05 Akzo Patente GmbH Wirkstoff enthaltende Formkörper
US4863744A (en) * 1984-09-17 1989-09-05 Alza Corporation Intestine drug delivery
US4720384A (en) * 1985-05-03 1988-01-19 E. I. Du Pont De Nemours And Company Manufacture of hollow fine tubular drug delivery systems
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
US4851232A (en) * 1987-02-13 1989-07-25 Alza Corporation Drug delivery system with means for obtaining desirable in vivo release rate pattern
US4975270A (en) * 1987-04-21 1990-12-04 Nabisco Brands, Inc. Elastomer encased active ingredients
US5510115A (en) * 1987-11-16 1996-04-23 Baxter Travenol Laboratories, Inc. Method and composition for administration of beneficial agent by controlled dissolution
JP2835402B2 (ja) * 1987-11-16 1998-12-14 バクスター、インターナショナル、インコーポレイテッド 有益な剤の投与のための微結晶性マトリックス
US5137669A (en) * 1988-03-02 1992-08-11 Endocon, Inc. Manufacture of partially fused peptide pellet
DE3827214A1 (de) * 1988-08-11 1990-02-15 Roehm Gmbh Retardierte arzneiform und verfahren zu ihrer herstellung
US5603956A (en) * 1990-11-27 1997-02-18 Labopharm Inc. Cross-linked enzymatically controlled drug release
US5153002A (en) * 1991-03-04 1992-10-06 University Of Montreal Biocompatible gradient controlled release implant
DE4118550C2 (de) * 1991-06-06 1996-09-26 Rademacher Karl Heinz Dr Rer N Tierarzneimittel
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
EP0620728B1 (en) * 1992-01-13 1997-01-08 Pfizer Inc. Preparation of tablets of increased strength
US5616343A (en) * 1993-03-25 1997-04-01 Labopharm, Inc. Cross-linked amylose as a binder/disintegrant in tablets
USD406187S (en) * 1996-04-19 1999-03-02 Reynaldo Garcia-Gutierrez Sausage
US5807575A (en) * 1997-02-14 1998-09-15 Rougier Inc. Manufacture of cross-linked amylose useful as a excipient for control release of active compounds
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US8545880B2 (en) * 1999-02-26 2013-10-01 Andrx Pharmaceuticals, Llc Controlled release oral dosage form
US6210716B1 (en) 1999-02-26 2001-04-03 Andrx Pharmaceuticals, Inc. Controlled release bupropion formulation
US6607748B1 (en) 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US6893660B2 (en) * 2002-11-21 2005-05-17 Andrx Pharmaceuticals, Inc. Stable pharmaceutical compositions without a stabilizer
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
WO2005102066A2 (en) 2004-04-20 2005-11-03 Wm. Wrigley Jr. Company Breath freshening confectionery products and methods of making and using same
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US8431150B2 (en) * 2005-02-07 2013-04-30 Wm. Wrigley Jr. Company Breath freshening confectionery products and methods of making and using same
US20060193909A1 (en) * 2005-02-07 2006-08-31 Stawski Barbara Z Breath freshening pressed tablets and methods of making and using same
CA2616204C (en) * 2005-09-09 2015-12-01 Labopharm Inc. Sustained drug release composition
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
US20130079749A1 (en) * 2007-08-29 2013-03-28 Advanced Bionics, Llc Modular Drug Delivery System for Minimizing Trauma During and After Insertion of a Cochlear Lead
TWI454288B (zh) 2008-01-25 2014-10-01 Gruenenthal Chemie 藥物劑型
PT2273983T (pt) 2008-05-09 2016-10-28 Gruenenthal Gmbh Processo para a preparação de uma formulação em pó intermediária e uma forma de dosagem sólida final sob utilização de uma etapa de congelamento por atomização
EA022886B1 (ru) * 2008-10-03 2016-03-31 Др. Фальк Фарма Гмбх Способ поддержания ремиссии язвенного колита у пациентов
ES2560210T3 (es) * 2009-07-22 2016-02-17 Grünenthal GmbH Forma de dosificación resistente a la manipulación para opiádes sensibles a la oxidación
CN102573805A (zh) 2009-07-22 2012-07-11 格吕伦塔尔有限公司 热熔挤出的控制释放剂型
TWI516286B (zh) 2010-09-02 2016-01-11 歌林達股份有限公司 含陰離子聚合物之抗破碎劑型
RU2604676C2 (ru) 2010-09-02 2016-12-10 Грюненталь Гмбх Устойчивая к разрушению лекарственная форма, содержащая неорганическую соль
LT2736495T (lt) 2011-07-29 2017-11-10 Grünenthal GmbH Sugadinimui atspari tabletė, pasižyminti greitu vaisto atpalaidavimu
CN103857386A (zh) 2011-07-29 2014-06-11 格吕伦塔尔有限公司 提供药物立即释放的抗破碎片剂
JP6117249B2 (ja) 2012-02-28 2017-04-19 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
CA2868142A1 (en) 2012-04-18 2013-10-24 Grunenthal Gmbh Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US9737490B2 (en) 2013-05-29 2017-08-22 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
CN105682643B (zh) 2013-07-12 2019-12-13 格吕伦塔尔有限公司 含有乙烯-醋酸乙烯酯聚合物的防篡改剂型
AU2014356581C1 (en) 2013-11-26 2020-05-28 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
EP3142646A1 (en) 2014-05-12 2017-03-22 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
US9872835B2 (en) 2014-05-26 2018-01-23 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping
CN107889459A (zh) 2015-04-24 2018-04-06 格吕伦塔尔有限公司 具有立即释放和对溶剂萃取的抗性的抗篡改剂型
EP3346991A1 (en) 2015-09-10 2018-07-18 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
USD862836S1 (en) * 2015-12-17 2019-10-15 Wm. Wrigley Jr. Company Textured confectionary
USD900930S1 (en) * 2018-08-20 2020-11-03 Twee, Inc. Sushi chalk
USD979179S1 (en) * 2021-09-23 2023-02-28 Perfetti Van Melle Spa Confectionery

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2478182A (en) * 1945-01-16 1949-08-09 William V Consolazio Sodium chloride tablet
GB630439A (en) * 1945-09-11 1949-10-13 Ethan Allan Brown Improvements in or relating to pharmaceutical preparations
CH283585A (de) * 1950-03-15 1952-06-15 Hoffmann La Roche Zur Herstellung von Tablettenüberzügen geeignetes Gemisch.
US2820741A (en) * 1954-04-29 1958-01-21 Abbott Lab Aluminum aspirin granulation and method for making
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation

Also Published As

Publication number Publication date
BE575313A (fr) 1959-05-29
US2987445A (en) 1961-06-06

Similar Documents

Publication Publication Date Title
ES248340A1 (es) Método para obtener una composicion en forma de dosificacion oral
ES401413A1 (es) Un procedimiento para preparar una composicion para la lim-pieza de metales.
CA535596A (en) Ammunition priming composition and process for producing same
ES45129U (es) Tapón perfeccionado
ES306378A1 (es) Procedimiento para la preparacion de una composicion para reprimir el desarrollo de microorganismos.
ES236259A1 (es) Un procedimiento de fabricaciën de maleato del 3-p-cloro-fenil-3-piripil-l dimetilaminopropano.
ES77057U (es) Chupete perfeccionado
ES267693A1 (es) Un procedimiento de preparaciën de la 2-hidroxi-3-metil-1-carbamida
ES239854A1 (es) Procedimiento para la obtencion de soluciones inyectables duraderas de alcaloides de rauwolfia
ES81770U (es) Dispositivo de sujeción para bolígrafos
JPS5235676A (en) Clock device
ES263103A1 (es) Proceso de preparaciën de grafito compacto
ES263191A1 (es) Un metodo para la preparaciën de una sustancia grasa
ES62214U (es) Envase-juego decorativo para caramelos
ES353197A1 (es) Un metodo para fortalecer un cuerpo fabricado de material vitreo o parcialmente vitreo.
AU230947B2 (en) Process of preparing agglomerated fuels, and agglomerated fuel pieces prepared by this process
ES65512U (es) Pieza metálica hueca y fundida
ES68035U (es) Dispositivo para la aplicación de sustancias medicamentosas
ES283562A2 (es) Mejoras introducidas en el objeto de la patente principal numero 266660
ES69912U (es) Complemento perfeccionado para tapones corona
ES262205A1 (es) Procedimiento de preparaciën de derivados 5-hidroxi 19-norandrostenicos
ES76107U (es) Candelilla sólida medicamentosa para usos nasales
ES74829U (es) Modelo de pieza cerámica para la construcción
ES243644A1 (es) Procedimiento para la preparaciën de derivados liposolubles de prednisona y prednisolona
ES258276A1 (es) Un procedimiento para la preparaciën de derivados esteroides